Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
New Drug Application for naloxegol accepted by United States Food and Drug Administration
-
AstraZeneca appoints architect for new global R&D centre and corporate headquarters in Cambridge, UK
-
AstraZeneca to invest £120 million in new manufacturing facility to produce Zoladex in Macclesfield
-
Marc Dunoyer appointed Chief Financial Officer of AstraZeneca
-
AstraZeneca PLC third quarter and nine months results 2013
-
AstraZeneca advances MedImmune’s benralizumab to Phase III in severe asthma
-
US appeals court issues decision in PULMICORT RESPULES patent litigation
-
AstraZeneca announces proposal to close Brixham Environmental Laboratory
-
AstraZeneca initiates phase III clinical programme for selumetinib, a treatment in development for patients with advanced or metastastic non-small-cell lung cancer
-
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability
Latest articles and press releases
All of our latest press releases and articles are available to explore
